IL-1 Receptor Antagonist Reduces Matrix Degradation in Human Intervertebral Discs
Author Information
Author(s): Le Maitre Christine L, Hoyland Judith A, Freemont Anthony J
Primary Institution: University of Manchester
Hypothesis
Matrix degradation in degeneration of the intervertebral disc (IVD) is inhibited by IL-1 receptor antagonist (IL-1Ra).
Conclusion
IL-1Ra can significantly inhibit matrix degradation in degenerate intervertebral discs.
Supporting Evidence
- IL-1Ra delivered directly onto explants of degenerate IVDs eliminates matrix degradation.
- There is a direct relationship between matrix degradation and MDP expression.
- Single injections of IVD cells engineered to over-express IL-1Ra significantly inhibit MDP expression for two weeks.
Takeaway
This study shows that a special medicine called IL-1Ra can help stop damage in the discs of our spine that can cause back pain.
Methodology
The study used in situ zymography and immunohistochemistry to assess matrix degradation and enzyme expression in human intervertebral disc samples.
Limitations
The study was conducted on human tissue samples, which may limit the generalizability of the findings.
Participant Demographics
The study included 18 cadaveric samples and 13 live patients, with a mix of ages and both sexes.
Statistical Information
P-Value
p < 0.01
Statistical Significance
p < 0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website